Benperidol

PHARMACOKINETICS

Absorption

Benperidol is well absorbed orally, with peak blood levels typically reached within 1–2 hours after administration. Its absorption can be affected by food, but overall it has goodbioavailability, allowing it to exert its therapeutic effects efficiently.

Distribution

Benperidol has a large volume of distribution (~4–5 L/kg), meaning most of the drug spreads into body tissues rather than remaining in the blood. Exact percentages in plasma versus tissues are not documented, but its pharmacokinetics indicate that a majority of the drug is tissue-bound after absorption.

Metabolism

Benperidol is primarily metabolized in the liver by hepatic enzymes, mainly through oxidation and reduction reactions. The metabolism produces several inactive metabolites, which are then excreted in the urine and feces. Liver function can influence the rate of benperidol clearance and its overall duration of action.

Excretion

Benperidol is excreted mainly through the urine, with a smaller portion eliminated in the feces. Both the parent drug and its inactive metabolites are removed from the body, and renal or hepatic impairment can affect the rate of excretion.

PHARMACODYNAMICS

Benperidol is a potent antipsychotic that works by blocking dopamine D2 receptors, helping reduce hallucinations, delusions, and severe behavioral disturbances. It also has minor effects on other receptors, which can cause sedation and other side effects.

ADMINISTRATION

Benperidol is usually administered orally as tablets or by intramuscular injection under medical supervision. The dose and frequency depend on the patient’s condition, age, and response, and careful monitoring is required due to potential side effects.

DOSAGE AND STRENGTH

• Oral tablets: typically 0.5 mg, 1 mg, or 5 mg per tablet. 

• Injectable form:usually 0.25 mg/mL to 1 mg/mL for intramuscular use. 

• Adults: often start with 0.5–2 mg per day, which can be gradually increased based on response. 

• Severe cases: doses up to 5–10 mg per day may be used under close supervision.

FOOD INTERACTIONS

Benperidol can be taken with or without food, as meals do not significantly affect its absorption. Alcohol should be avoided, since it can increase sedation and impair coordination when used with the drug.

DRUG INTERACTIONS

Benperidol can interact with other CNS-active drugs, sedatives, or liver enzyme modulators, which may increase side effects like sedation, low blood pressure, or altered drug levels. Careful monitoring is needed when it is taken with such medications.

CONTRAINDICATIONS

• Severe central nervous system depression or comatose states

• Known hypersensitivity to benperidol or other butyrophenones

• Parkinson’s disease or other conditions with dopamine deficiency

• Severe heart problems, including arrhythmias or recent heart attacks

• Liver or kidney failure where drug clearance is impaired

SIDE EFFECTS

• Sedation and drowsiness

• Extrapyramidal symptoms (tremors, rigidity, restlessness)

• Low blood pressure (hypotension)

• Dry mouth, constipation, or blurred vision

• Hormonal effects such as increased prolactin

TOXICITY

Benperidol toxicity can cause extreme sedation, severe movement disorders, low blood pressure, and in rare cases, neuroleptic malignant syndrome or seizures. Treatment is supportive, focusing on stabilizing vital signs and managing complications.